Andrew Mellor, PhD, received a $1.5M, 4-year R01 grant from NIAID/NIH for “Engineering DNA nanoparticles to create immune tolerance.”

Dr. Mellor’s laboratory has observed physiologic responses to DNA nanoparticles in mice, founding a completely novel approach to manipulating immune responses and protecting healthy tissues from destruction during autoimmune syndromes. This grant will explore key elements of the pathway targeted by the DNA nanoparticles and will engineer vaccines to protect healthy tissues at risk of immune-mediated destruction in mouse models of clinical autoimmune syndromes. DNA nanoparticles are also used to incite anti-tumor immunity, and a future direction is to evaluate if cancer therapeutic responses to DNA nanoparticles are sub-optimal due to the tolerogenic responses documented by Dr. Mellor’s laboratory.

Written by
Allison Brown
View all articles
Written by Allison Brown

About Jagwire

Jagwire is the official source for news and stories from Augusta University and AU Health. Daily updates highlight the many ways students, faculty, staff, researchers and clinicians "bring their A games" in classrooms and clinics on four campuses in Augusta and locations across the state of Georgia. Read on for stories of innovation in education and health care, opportunities at the center of Georgia’s new cybersecurity hub, and experiential learning that blends arts and application, humanities and the health sciences. Have a story to share with Jaguar Nation? Contact the Division of Communications & Marketing.